BibTex RIS Cite

WELLS SENDROMLU HASTADA DAPSONA BAĞLI METHEMOGLOBİNEMİ GELİŞİMİ: OLGU SUNUMU

Year 2016, Volume: 79 Issue: 2, 97 - 100, 02.08.2016
https://doi.org/10.18017/iuitfd.01209

Abstract

Amaç: Wells sendromu (eozinofilik sellülit), prodromal yanma veya kaşınmayla başlayan eritematöz papül, nodül, büller şeklinde, çeşitli morfolojilerde ve ciddiyette aylar, yıllar boyu persistan veya rekürren erüpsiyonlarla seyreden nadir bir inflamatuvar dermatozdur. Etiyoloji net olmamakla birlikte böcek ısırıkları, hematolojik bozukluklar, maligniteler, enfeksiyonlar ve çeşitli ilaçlarla ilgili bildirimler mevcuttur. Hastalığın klinik aktivitesiyle periferik kanda IL5, kan ve kemik iliğinde eozinofil seviyeleri arasında korelasyon olduğu gösterilmiştir. Histopatolojik olarak akut dönemde dermiste ödem ve eozinofillerden zengin infiltrat, subakut dönemde kollagen bantları çevreleyen eozinofillerin degranülasyonuyla ‘’alev figürleri’’ ve sonrasında alev figürleri etrafında fagositik histiyositler ve dev hücreleri görülür; vaskülit bulguları yoktur. Burada akut farenjit sebebi ile antibiyotik kullanımı sonrası vücudunda yaygın ürtikeryal döküntüleri başlayan hastada Wells Sendromu tanısı koyduğumuzu ve dapson tedavisi sonrası methemoglobinemi gelişimini bildirmek istedik.

Olgu: 24 yaşında kadın, amoksisilin klavulanik asit tedavisi sonrası tüm vücutta yaygın ürtikeryal lezyonlar ile polikliniğimize başvurdu. Lezyonlar anüler görünümde, eritemli, merkezi soluk, endüre plaklar şeklinde olup oral metilprednizolon/setirizin/topikal mometazon tedavisiyle düzeldikten sonra nüks gelişmiş; 6 hafta süre ile kullanılan hidroksiklorokine direnç sebebi ile dapson başlanmıştı. 2x100 mg dapson tedavisinin 5. gününde şiddetli baş ağrısı, baş dönmesi, çarpıntı, hâlsizlik, huzursuzluk sonrası methemoglobin: % 5.10 saptanan hastada dapsona bağlı methemoglobinemi düşünüldü ve olgu destek tedavi ile takip edildi.

Sonuç: Wells sendromunda tedavinin temelini kortikosteroidler oluşturur; antihistaminikler, hidroksiklorokin, griseofulvin, dapson ve gereğinde immunsupresanlar (siklosporin, azotioprin, takrolimus) kullanılabilir. Dapson kullanan hastalar methemoglobinemi açısından yakından takip edilmeli ve gereğinde etkili bir şekilde tedavi edilmelidir. 

Anahtar kelimeler: Eozinofilik sellülit; dapson; methemoglobinemi.

References

  • Wells GC, Smith NP. Eosinophilic cellulitis. Br J. Dermatol 1979;100:101-9.
  • Seçkin D, Demirhan B. Drugs and Wells’ syndrome: a possible causal relationship?.Int J Dermatol 2001;40(2):138-140.
  • Albayrak H, Yanık ME, Güvenç SC, Küçükçakır O, Yıldırım M. Eozinofilik Sellülit (Wells Sendromu): Olgu Sunumu Düzce Üniversitesi Tıp Fakültesi Dergisi 2009;11(3):42-4.
  • Ghislain PD, Van Eeckhout P. Eosinophilic cellulitis of papulonodular presentation. Journal of the European Academy of Dermatology and Venereology 2005;19:226-7.
  • Espa A, Sanz ML, Sola J, Gil P. Wells’ syndrome (eosinophilic cellulitis): correlation between clinical activity, eosinophil levels, eosinophil cation protein and interleukin-5. Br J Dermatol 1999;140:127-30.
  • Katırcı Y, Başpınar İ, Karamercan MA, Coşkun F. Yüksek doz dapson alımına bağlı methemoglobinemi olgusu.Düzce Tıp Fakültesi Dergisi 2014;16(3): 40-1.
  • Burke P, Jahangir K, Kolber MR. Dapsone-induced methemoglobinemia: Case of the blue lady. Can Fam Physician 2013;59:958-61.
  • Moossavi M, Mehregan DR. Wells’ syndrome: a clinical and histopathologic review of seven cases. Mehregan supplement report 2003;42:62-7.
  • Weiss G, Shemer A, Confino Y, Kaplan B, Trau H. Wells’ syndrome: report of a case and review of literature. Int J Dermatol 2001;40:133-52.
  • Brar R, Eshaghian S, Eshaghian S, B P Miles. Acute Dapsone-Induced Methemoglobinemia in a 24-YearOld Woman with Ulcerative Colitis. Hospital Physician 200;54–8.

DAPSONE-INDUCED METHEMOGLOBINEMIA IN A PATIENT WITH WELLS SYNDROME: A CASE REPORT

Year 2016, Volume: 79 Issue: 2, 97 - 100, 02.08.2016
https://doi.org/10.18017/iuitfd.01209

Abstract

Wells
syndrome (eosinophilic cellulitis), is a rare inflammatory dermatosis
characterized by persistent/recurrent erythematous papules, nodules, blisters
with various morphology and severity. Etiology is not clear, although insect
bites, hematological disorders, malignancies, infections and various drugs have
been reported. It has been shown that clinical disease activity is correlated
with IL5 level/eosinophils in peripheral blood and bone marrow.
Histopathological examination shows edema and eosinophil-rich infiltrate of
dermis in acute period, “flame figures” via degranulation of eosinophils
surrounding collagen bands in subacute period, phagocytic
histiocytes and giant cells around the flame figures in remission period;
vasculitis
is not present. Herein we report a case with widespread urticarial eruptions
after antibiotic use for acute pharyngitis diagnosed as Wells Syndrome and
developed methemoglobinemia after dapsone treatment.

Case: A 24
year old woman, was admitted to our outpatient clinic with common urticarial lesions
after treatment with amoxicillin clavulanic acid. Lesions were annular,
erythematous, indurated plaques with changing diameters.. A relapse was occured
after oral methylprednisolone/cetirizine/topical mometasone treatment. After
treatment resistance with hydroxychloroquine for 6 weeks, dapsone was started.
On the 5th day of 2x100 mg dapsone treatment severe headache, dizziness,
palpitations, fatigue, was considered methemoglobinemia: Dapsone induced
methemoglobinemia was shown with 5.10 % methemoglobin level and followed up
with supportive treatment.

Conclusıon: The basis for the treatment of Wells syndrome is
corticosteroids; while antihistamines, hidroksikloroquin, griseofulvin, dapsone
and immunosupressants (cyclosporine, azathioprine, tacrolimus) can be used. Patients using dapsone should be monitored closely for
methemoglobinemia and treated effectively
as needed.







Keywords: eosinophilic cellulitis, dapson, methemoglobinemia,

References

  • Wells GC, Smith NP. Eosinophilic cellulitis. Br J. Dermatol 1979;100:101-9.
  • Seçkin D, Demirhan B. Drugs and Wells’ syndrome: a possible causal relationship?.Int J Dermatol 2001;40(2):138-140.
  • Albayrak H, Yanık ME, Güvenç SC, Küçükçakır O, Yıldırım M. Eozinofilik Sellülit (Wells Sendromu): Olgu Sunumu Düzce Üniversitesi Tıp Fakültesi Dergisi 2009;11(3):42-4.
  • Ghislain PD, Van Eeckhout P. Eosinophilic cellulitis of papulonodular presentation. Journal of the European Academy of Dermatology and Venereology 2005;19:226-7.
  • Espa A, Sanz ML, Sola J, Gil P. Wells’ syndrome (eosinophilic cellulitis): correlation between clinical activity, eosinophil levels, eosinophil cation protein and interleukin-5. Br J Dermatol 1999;140:127-30.
  • Katırcı Y, Başpınar İ, Karamercan MA, Coşkun F. Yüksek doz dapson alımına bağlı methemoglobinemi olgusu.Düzce Tıp Fakültesi Dergisi 2014;16(3): 40-1.
  • Burke P, Jahangir K, Kolber MR. Dapsone-induced methemoglobinemia: Case of the blue lady. Can Fam Physician 2013;59:958-61.
  • Moossavi M, Mehregan DR. Wells’ syndrome: a clinical and histopathologic review of seven cases. Mehregan supplement report 2003;42:62-7.
  • Weiss G, Shemer A, Confino Y, Kaplan B, Trau H. Wells’ syndrome: report of a case and review of literature. Int J Dermatol 2001;40:133-52.
  • Brar R, Eshaghian S, Eshaghian S, B P Miles. Acute Dapsone-Induced Methemoglobinemia in a 24-YearOld Woman with Ulcerative Colitis. Hospital Physician 200;54–8.
There are 10 citations in total.

Details

Subjects Health Care Administration
Journal Section Case Reports
Authors

Orkide Kutlu

Emek Özgür Kocatürk This is me

Kübra Cüre This is me

Cuyan Demirkesen This is me

Hasan Eruzun

Tufan Tükek

Publication Date August 2, 2016
Submission Date March 28, 2016
Published in Issue Year 2016 Volume: 79 Issue: 2

Cite

APA Kutlu, O., Kocatürk, E. Ö., Cüre, K., Demirkesen, C., et al. (2016). DAPSONE-INDUCED METHEMOGLOBINEMIA IN A PATIENT WITH WELLS SYNDROME: A CASE REPORT. Journal of Istanbul Faculty of Medicine, 79(2), 97-100. https://doi.org/10.18017/iuitfd.01209
AMA Kutlu O, Kocatürk EÖ, Cüre K, Demirkesen C, Eruzun H, Tükek T. DAPSONE-INDUCED METHEMOGLOBINEMIA IN A PATIENT WITH WELLS SYNDROME: A CASE REPORT. İst Tıp Fak Derg. August 2016;79(2):97-100. doi:10.18017/iuitfd.01209
Chicago Kutlu, Orkide, Emek Özgür Kocatürk, Kübra Cüre, Cuyan Demirkesen, Hasan Eruzun, and Tufan Tükek. “DAPSONE-INDUCED METHEMOGLOBINEMIA IN A PATIENT WITH WELLS SYNDROME: A CASE REPORT”. Journal of Istanbul Faculty of Medicine 79, no. 2 (August 2016): 97-100. https://doi.org/10.18017/iuitfd.01209.
EndNote Kutlu O, Kocatürk EÖ, Cüre K, Demirkesen C, Eruzun H, Tükek T (August 1, 2016) DAPSONE-INDUCED METHEMOGLOBINEMIA IN A PATIENT WITH WELLS SYNDROME: A CASE REPORT. Journal of Istanbul Faculty of Medicine 79 2 97–100.
IEEE O. Kutlu, E. Ö. Kocatürk, K. Cüre, C. Demirkesen, H. Eruzun, and T. Tükek, “DAPSONE-INDUCED METHEMOGLOBINEMIA IN A PATIENT WITH WELLS SYNDROME: A CASE REPORT”, İst Tıp Fak Derg, vol. 79, no. 2, pp. 97–100, 2016, doi: 10.18017/iuitfd.01209.
ISNAD Kutlu, Orkide et al. “DAPSONE-INDUCED METHEMOGLOBINEMIA IN A PATIENT WITH WELLS SYNDROME: A CASE REPORT”. Journal of Istanbul Faculty of Medicine 79/2 (August 2016), 97-100. https://doi.org/10.18017/iuitfd.01209.
JAMA Kutlu O, Kocatürk EÖ, Cüre K, Demirkesen C, Eruzun H, Tükek T. DAPSONE-INDUCED METHEMOGLOBINEMIA IN A PATIENT WITH WELLS SYNDROME: A CASE REPORT. İst Tıp Fak Derg. 2016;79:97–100.
MLA Kutlu, Orkide et al. “DAPSONE-INDUCED METHEMOGLOBINEMIA IN A PATIENT WITH WELLS SYNDROME: A CASE REPORT”. Journal of Istanbul Faculty of Medicine, vol. 79, no. 2, 2016, pp. 97-100, doi:10.18017/iuitfd.01209.
Vancouver Kutlu O, Kocatürk EÖ, Cüre K, Demirkesen C, Eruzun H, Tükek T. DAPSONE-INDUCED METHEMOGLOBINEMIA IN A PATIENT WITH WELLS SYNDROME: A CASE REPORT. İst Tıp Fak Derg. 2016;79(2):97-100.

Contact information and address

Addressi: İ.Ü. İstanbul Tıp Fakültesi Dekanlığı, Turgut Özal Cad. 34093 Çapa, Fatih, İstanbul, TÜRKİYE

Email: itfdergisi@istanbul.edu.tr

Phone: +90 212 414 21 61